Udi Meirav - Net Worth and Insider Trading

Udi Meirav Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Udi Meirav owns 1 companies in total, including Candel Therapeutics Inc (CADL) .

Click here to see the complete history of Udi Meirav’s form 4 insider trades.

Insider Ownership Summary of Udi Meirav

Ticker	Comapny	Transaction Date	Type of Owner
CADL	Candel Therapeutics Inc	2021-07-26	director

Udi Meirav Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Udi Meirav Ownership Network

Ownership Network List of Udi Meirav

No Data

Ownership Network Relation of Udi Meirav

Udi Meirav Owned Company Details

What does Candel Therapeutics Inc do?

Who are the key executives at Candel Therapeutics Inc?

Udi Meirav is the director of Candel Therapeutics Inc. Other key executives at Candel Therapeutics Inc include director & Chief Scientific Officer Estuardo Aguilar-cordova , Chief Medical Officer William Garrett Nichols , and See Remarks Seshu Tyagarajan .

Candel Therapeutics Inc (CADL) Insider Trades Summary

Over the past 18 months, Udi Meirav made no insider transaction in Candel Therapeutics Inc (CADL). Other recent insider transactions involving Candel Therapeutics Inc (CADL) include a net sale of 75,414 shares made by Estuardo Aguilar-cordova , a net sale of 42,821 shares made by Paul Peter Tak , and a net sale of 28,181 shares made by Seshu Tyagarajan .

In summary, during the past 3 months, insiders sold 75,414 shares of Candel Therapeutics Inc (CADL) in total and bought 0 shares, with a net sale of 75,414 shares. During the past 18 months, 212,537 shares of Candel Therapeutics Inc (CADL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,537 shares.

Candel Therapeutics Inc (CADL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Candel Therapeutics Inc Insider Transactions

No Available Data

Udi Meirav Mailing Address

Above is the net worth, insider trading, and ownership report for Udi Meirav. You might contact Udi Meirav via mailing address: Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham Ma 02494.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.